Taipei, April 9 (CNA) A COVID-19 vaccine being developed by the National Health Research Institutes (NHRI) has produced promising results in mice, although further research is needed to determine its effectiveness against the disease, NHRI President Liang Kung-yee (梁賡義) said Wednesday.
The NHRI has been working on developing four kinds of vaccines against the COVID-19 coronavirus since February, with the development of a peptide vaccine progressing the fastest, Liang told CNA.
Peptides are a chain of amino acids that are the building blocks that form proteins.
According to Liang, when the peptide vaccine has been injected into mice, they have produced antibodies that seem promising, although further research is needed to determine whether these antibodies can help mice sufficiently combat SARS-CoV-2, the virus that causes COVID-19.
Read more: Focus Taiwan
ABOUT PTIC TAIPEI
The Philippine Trade & Investment Center in Taipei is the Commercial Affairs Section of the Manila Economic and Cultural Office and the representative office of the Philippine Department of Trade & Industry in Taiwan